Research labIndependently curated · Unclaimed

Stephen W. Fesik Research Group

Vanderbilt University
Research lead
Stephen W. Fesik
Department
Biochemistry
Recruiting
Availability unconfirmed
Updated
November 20, 2026

Research focus

drug discoverycancerNMRfragment-based screeningstructure-based design

About the research

Can fragment-based methods and structure-based design be used to find drugs for hard-to-drug cancer targets?

Read the full research overview

Stephen Fesik is a Professor of Biochemistry, Pharmacology and Chemistry who holds the Orrin H. Ingram II Chair in Cancer Research. The Fesik lab uses fragment-based methods to identify small molecules, called fragments, that bind to difficult targets and structure-based design to optimize them for binding to the target protein. Current projects include discovery of KRAS inhibitors, WDR5 inhibitors and MYC/MAX inhibitors. The lab also works on the development of new NMR methods for fragment screening.

Selected publications

3 listed

People & alumni

Team details haven’t been added. See the lab’s website for its current members.

Alumni details haven’t been added. Check the lab’s official website.

Sources & listing information

Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.

Request a correction or removal ↗ · About directory listings

Related research labs

More labs at Vanderbilt University →Research labs in United States →